Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices Civilians of Lyons, shared a post on X:
“Phase 3 DeLLphi-304 is clinical trial evaluating Tarlatamab vs SOC chemo in SCLC who progressed after front-line platinum-based chemo met its primary endpoint of OS. Can’t wait to see the data.”